_id

690db168ccc777a4e85d0bef

Ticker

ASBPW

Name

Aspire Biopharma Holdings, Inc.

Exchange

NASDAQ

Address

23150 Fashion Drive, Estero, FL, United States, 33928

Country

USA

Sector

Industry

Currency

USD

Website

https://aspirebiolabs.com

Description

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

Last Close

0.0196

Volume

45501

Current Price

0.0175

Change

-0.0023

Last Updated

2026-01-20T15:43:43.090Z

Image

data:image/webp;base64,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

Ipo Date

2022-04-11T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

1941

Cost Of Revenue

1057

Gross Profit

884

Operating Expenses

1146381

Operating Income

-1145497

Interest Expense

1480058

Pretax Income

-1850493

Net Income

-1850493

Eps

-0.03736409402985948

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-

EBITDA

-

Operating Margin

-59015.816589386915

Total Other Income Expense Net

-704996

Cash

1948271

Short Term Investments

-

Receivables

-

Inventories

35437

Total Current Assets

2403129

Property Plant Equipment

-

Total Assets

2403129

Payables

1060889

Short Term Debt

8624743

Long Term Debt

-

Total Liabilities

13870407

Equity

-11467278

Bs_currency_symbol

USD

Depreciation

2021208

Change In Working Capital

1637031

Cash From Operations

-1103809

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

2845847

Net Change In Cash

1742038

Cf_currency_symbol

USD

PE

-

PB

-0.07558066308325308

ROE

16.13716001303884

ROA

-77.00348171071964

FCF

-1103809

Fcf Percent

-568.6805770221536

Piotroski FScore

1

Health Score

28

Deep Value Investing Score

0

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

1.5

Growth Investing Score

1

Momentum Investing Score

2

Net Net Investing Score

0

Quality Investing Score

1.5

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

1941

Quarters > 0 > income Statement > cost Of Revenue

1057

Quarters > 0 > income Statement > gross Profit

884

Quarters > 0 > income Statement > operating Expenses

1146381

Quarters > 0 > income Statement > operating Income

-1145497

Quarters > 0 > income Statement > interest Expense

1480058

Quarters > 0 > income Statement > pretax Income

-1850493

Quarters > 0 > income Statement > net Income

-1850493

Quarters > 0 > income Statement > eps

-0.03736409402985948

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

49525970

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

-59015.816589386915

Quarters > 0 > income Statement > total Other Income Expense Net

-704996

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

1948271

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

35437

Quarters > 0 > balance Sheet > total Current Assets

2403129

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

2403129

Quarters > 0 > balance Sheet > payables

1060889

Quarters > 0 > balance Sheet > short Term Debt

8624743

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

13870407

Quarters > 0 > balance Sheet > equity

-11467278

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-1850493

Quarters > 0 > cash Flow > depreciation

2021208

Quarters > 0 > cash Flow > change In Working Capital

1637031

Quarters > 0 > cash Flow > cash From Operations

-1103809

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

2845847

Quarters > 0 > cash Flow > net Change In Cash

1742038

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.03736409402985948

Quarters > 0 > ratios > PB

-0.07558066308325308

Quarters > 0 > ratios > ROE

16.13716001303884

Quarters > 0 > ratios > ROA

-77.00348171071964

Quarters > 0 > ratios > FCF

-1103809

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-568.6805770221536

Quarters > 0 > health Score

28

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

799890

Quarters > 1 > income Statement > operating Income

-799890

Quarters > 1 > income Statement > interest Expense

527893

Quarters > 1 > income Statement > pretax Income

-1981293

Quarters > 1 > income Statement > net Income

-1981293

Quarters > 1 > income Statement > eps

-0.04016107703498678

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

49333662

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1453400

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-1181403

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

206233

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

989422

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

989422

Quarters > 1 > balance Sheet > payables

1351639

Quarters > 1 > balance Sheet > short Term Debt

8473423

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

10606207

Quarters > 1 > balance Sheet > equity

-9616785

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

-1981293

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-260034

Quarters > 1 > cash Flow > cash From Operations

-1140310

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-1140310

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.04016107703498678

Quarters > 1 > ratios > PB

-0.08977419012694993

Quarters > 1 > ratios > ROE

20.602446659668487

Quarters > 1 > ratios > ROA

-200.24751824802763

Quarters > 1 > ratios > FCF

-1140310

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

15556000

Quarters > 2 > income Statement > operating Income

-15556000

Quarters > 2 > income Statement > interest Expense

289931

Quarters > 2 > income Statement > pretax Income

-15941000

Quarters > 2 > income Statement > net Income

-15941000

Quarters > 2 > income Statement > eps

-0.42071576892899637

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

37890189

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-15651000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

-385000

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

1346543

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

1965514

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

1965514

Quarters > 2 > balance Sheet > payables

1432025

Quarters > 2 > balance Sheet > short Term Debt

6764182

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

8918256

Quarters > 2 > balance Sheet > equity

-6952742

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

-15941328

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-326298

Quarters > 2 > cash Flow > cash From Operations

-1751528

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

3094438

Quarters > 2 > cash Flow > net Change In Cash

1342910

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.42071576892899637

Quarters > 2 > ratios > PB

-0.09536932443343936

Quarters > 2 > ratios > ROE

229.27644949287634

Quarters > 2 > ratios > ROA

-811.0346708291063

Quarters > 2 > ratios > FCF

-1751528

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

2518000

Quarters > 3 > income Statement > operating Income

-2518000

Quarters > 3 > income Statement > interest Expense

491634

Quarters > 3 > income Statement > pretax Income

-11967000

Quarters > 3 > income Statement > net Income

-11966000

Quarters > 3 > income Statement > eps

-1.5409888084496566

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

7765144

Quarters > 3 > income Statement > income Tax Expense

-1013

Quarters > 3 > income Statement > EBITDA

-11075000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

-9448801

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

3633

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

36503

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

147989

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

147989

Quarters > 3 > balance Sheet > payables

310219

Quarters > 3 > balance Sheet > short Term Debt

1266832

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

1688077

Quarters > 3 > balance Sheet > equity

-1540088

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-738500

Quarters > 3 > cash Flow > depreciation

0

Quarters > 3 > cash Flow > change In Working Capital

1218069

Quarters > 3 > cash Flow > cash From Operations

479569

Quarters > 3 > cash Flow > capital Expenditures

4

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-492477

Quarters > 3 > cash Flow > net Change In Cash

-12908

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-1.5409888084496566

Quarters > 3 > ratios > PB

-0.08823523071408908

Quarters > 3 > ratios > ROE

776.9685888079123

Quarters > 3 > ratios > ROA

-8085.736102007581

Quarters > 3 > ratios > FCF

479565

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

40

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

0

Annuals > 0 > income Statement > cost Of Revenue

-

Annuals > 0 > income Statement > gross Profit

-

Annuals > 0 > income Statement > operating Expenses

3089000

Annuals > 0 > income Statement > operating Income

-3088671

Annuals > 0 > income Statement > interest Expense

891624

Annuals > 0 > income Statement > pretax Income

-12537000

Annuals > 0 > income Statement > net Income

-12537000

Annuals > 0 > income Statement > eps

-1.520707863613477

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

8244187

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-11646000

Annuals > 0 > income Statement > operating Margin

-

Annuals > 0 > income Statement > total Other Income Expense Net

-9448801

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

3633

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

36503

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

147989

Annuals > 0 > balance Sheet > property Plant Equipment

-

Annuals > 0 > balance Sheet > total Assets

147989

Annuals > 0 > balance Sheet > payables

310219

Annuals > 0 > balance Sheet > short Term Debt

1266832

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

1688077

Annuals > 0 > balance Sheet > equity

-1540088

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-1309872

Annuals > 0 > cash Flow > depreciation

0

Annuals > 0 > cash Flow > change In Working Capital

1044686

Annuals > 0 > cash Flow > cash From Operations

-265186

Annuals > 0 > cash Flow > capital Expenditures

0

Annuals > 0 > cash Flow > cash From Investing

13781323

Annuals > 0 > cash Flow > cash From Financing

257645

Annuals > 0 > cash Flow > net Change In Cash

-7541

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-1.520707863613477

Annuals > 0 > ratios > PB

-0.09367859011952565

Annuals > 0 > ratios > ROE

814.0443922684938

Annuals > 0 > ratios > ROA

-8471.575590077642

Annuals > 0 > ratios > FCF

-265186

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-

Annuals > 0 > health Score

31

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

0

Annuals > 1 > income Statement > cost Of Revenue

0

Annuals > 1 > income Statement > gross Profit

0

Annuals > 1 > income Statement > operating Expenses

1340000

Annuals > 1 > income Statement > operating Income

-1340168

Annuals > 1 > income Statement > interest Expense

8966

Annuals > 1 > income Statement > pretax Income

4464000

Annuals > 1 > income Statement > net Income

4464000

Annuals > 1 > income Statement > eps

0.5414724338494505

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

8244187

Annuals > 1 > income Statement > income Tax Expense

481

Annuals > 1 > income Statement > EBITDA

4473000

Annuals > 1 > income Statement > operating Margin

-

Annuals > 1 > income Statement > total Other Income Expense Net

5804247

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

11174

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

-

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

46174

Annuals > 1 > balance Sheet > property Plant Equipment

-

Annuals > 1 > balance Sheet > total Assets

46174

Annuals > 1 > balance Sheet > payables

172773

Annuals > 1 > balance Sheet > short Term Debt

360636

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

534035

Annuals > 1 > balance Sheet > equity

-487861

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-359070

Annuals > 1 > cash Flow > depreciation

0

Annuals > 1 > cash Flow > change In Working Capital

370206

Annuals > 1 > cash Flow > cash From Operations

11136

Annuals > 1 > cash Flow > capital Expenditures

3

Annuals > 1 > cash Flow > cash From Investing

284916127

Annuals > 1 > cash Flow > cash From Financing

-284760279

Annuals > 1 > cash Flow > net Change In Cash

11136

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

0.5414724338494505

Annuals > 1 > ratios > PB

-0.2957261853273781

Annuals > 1 > ratios > ROE

-915.0147275555946

Annuals > 1 > ratios > ROA

9667.778403430502

Annuals > 1 > ratios > FCF

11133

Annuals > 1 > ratios > Piotroski FScore

2

Annuals > 1 > ratios > fcf Percent

-

Annuals > 1 > health Score

58

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

0

Annuals > 2 > income Statement > cost Of Revenue

0

Annuals > 2 > income Statement > gross Profit

0

Annuals > 2 > income Statement > operating Expenses

976345

Annuals > 2 > income Statement > operating Income

-976345

Annuals > 2 > income Statement > interest Expense

0

Annuals > 2 > income Statement > pretax Income

-596374

Annuals > 2 > income Statement > net Income

-597000

Annuals > 2 > income Statement > eps

-0.07241466017207034

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

8244187

Annuals > 2 > income Statement > income Tax Expense

626

Annuals > 2 > income Statement > EBITDA

-596000

Annuals > 2 > income Statement > operating Margin

-

Annuals > 2 > income Statement > total Other Income Expense Net

379971

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

38

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

-

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

22538

Annuals > 2 > balance Sheet > property Plant Equipment

-

Annuals > 2 > balance Sheet > total Assets

22538

Annuals > 2 > balance Sheet > payables

122734

Annuals > 2 > balance Sheet > short Term Debt

27967

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

151328

Annuals > 2 > balance Sheet > equity

-128790

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-597117

Annuals > 2 > cash Flow > depreciation

0

Annuals > 2 > cash Flow > change In Working Capital

454212

Annuals > 2 > cash Flow > cash From Operations

-142905

Annuals > 2 > cash Flow > capital Expenditures

4895106

Annuals > 2 > cash Flow > cash From Investing

-4895106

Annuals > 2 > cash Flow > cash From Financing

4852552

Annuals > 2 > cash Flow > net Change In Cash

-185458

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-0.07241466017207034

Annuals > 2 > ratios > PB

-1.120221076946968

Annuals > 2 > ratios > ROE

463.5453063126019

Annuals > 2 > ratios > ROA

-2648.859703611678

Annuals > 2 > ratios > FCF

-5038011

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-

Annuals > 2 > health Score

30

Valuation > metrics > PE

-0.03736409402985948

Valuation > metrics > PB

-0.07558066308325308

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

16.13716001303884

Profitability > metrics > ROA

-77.00348171071964

Profitability > metrics > Net Margin

-953.370942812983

Profitability > final Score

32

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-0.7739541288246812

Risk > final Score

27

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.24811277157752845

Liquidity > metrics > Quick Ratio

0.24445405317897687

Liquidity > final Score

22

Liquidity > verdict

Weak

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

55

Prev Profitabilities > 1

55

Prev Profitabilities > 2

55

Prev Risks > 0

24

Prev Risks > 1

-185

Prev Risks > 2

10

Prev Liquidities > 0

15

Prev Liquidities > 1

22

Prev Liquidities > 2

15

Updated At

2026-01-20T21:25:06.892Z